Total Payments
$864.86
2024 Payments
$397.92
Companies
6
Transactions
8

Payment Breakdown by Category

Food & Beverage$864.86 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $864.86 8 100.0%

Top Paying Companies

Company Total Records Latest Year
E.R. Squibb & Sons, L.L.C. $231.15 2 $0 (2024)
Boston Scientific Corporation $136.51 2 $0 (2024)
Evoke Pharma, Inc. $124.74 1 $0 (2023)
Phathom Pharmaceuticals, Inc. $124.74 1 $0 (2024)
Regeneron Healthcare Solutions, Inc. $124.00 1 $0 (2023)
Madrigal Pharmaceuticals $123.72 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $397.92 4 Phathom Pharmaceuticals, Inc. ($124.74)
2023 $466.94 4 Evoke Pharma, Inc. ($124.74)

All Payment Transactions

8 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
12/05/2024 Madrigal Pharmaceuticals REZDIFFRA (Drug) Food and Beverage In-kind items and services $123.72 General
Category: LIVER DISEASE
11/20/2024 Boston Scientific Corporation Axios (Device) Food and Beverage In-kind items and services $27.51 General
Category: Axios_ENDO
03/05/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $124.74 General
Category: GASTROENTEROLOGY
02/07/2024 E.R. Squibb & Sons, L.L.C. ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $121.95 General
Category: Neuroscience
11/15/2023 Evoke Pharma, Inc. GIMOTI (Drug) Food and Beverage In-kind items and services $124.74 General
Category: Gastroenterology
09/26/2023 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $124.00 General
Category: INFLAMMATION AND IMMUNOLOGY
08/31/2023 Boston Scientific Corporation WallFlex Duodenal (Device) Food and Beverage In-kind items and services $109.00 General
Category: WallFlex_ENDO
07/18/2023 E.R. Squibb & Sons, L.L.C. ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $109.20 General
Category: Neuroscience

About Dr. Michael Harring, MD

Dr. Michael Harring, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Falls Church, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2020. The National Provider Identifier (NPI) number assigned to this provider is 1942825708.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Harring, MD has received a total of $864.86 in payments from pharmaceutical and medical device companies, with $397.92 received in 2024. These payments were reported across 8 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($864.86).

Practice Information

Products in Payments

  • ZEPOSIA (Drug) $231.15
  • GIMOTI (Drug) $124.74
  • VOQUEZNA (Drug) $124.74
  • DUPIXENT (Biological) $124.00
  • REZDIFFRA (Drug) $123.72
  • WallFlex Duodenal (Device) $109.00
  • Axios (Device) $27.51

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Falls Church